Fibroblast growth factor 21 serum concentrations in patients with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (DM2). (August 2018)

Record Type:: Journal Article
Title:: Fibroblast growth factor 21 serum concentrations in patients with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (DM2). (August 2018)
Main Title:: Fibroblast growth factor 21 serum concentrations in patients with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (DM2).
Authors:: Walus-miarka, M.
Idzior-Walus, B.
Kapusta, M.
Trojak, A.
Miarka, P.
Malecki, M.T.
Abstract:
Is Part Of:: Atherosclerosis. Volume 275(2018)
Journal:: Atherosclerosis
Issue:: Volume 275(2018)
Issue Display:: Volume 275, Issue 2018 (2018)
Year:: 2018
Volume:: 275
Issue:: 2018
Issue Sort Value:: 2018-0275-2018-0000
Page Start:: e151
Page End:
Publication Date:: 2018-08
Subjects:: Arteriosclerosis -- Periodicals
Electronic journals
616.136
Journal URLs:: http://www.sciencedirect.com/science/journal/00219150 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/00219150 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.atherosclerosis.2018.06.449 ↗
Languages:: English
ISSNs:: 0021-9150
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1765.874000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 10649.xml